A new report based on chronic myelogenous leukemia treatment titled “Chronic Myelogenous Leukemia Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026” has recently been added to the database of Market Research Reports Search Engine (MRRSE). According to the report, a value of US$ 8,550.8 million is estimated to be generated by the global chronic myelogenous leukemia treatment market by the end of 2025. The report further ... Read more

Dasatinib is a potent and targeted cancer drug belonging to a class of medications known as tyrosine kinase inhibitors (TKIs). It was initially developed to treat chronic myeloid leukemia (CML) and later found application in the management of other malignancies, notably Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL) and certain types of solid tumors. This article aims to provide an in-depth exploration of Dasatinib's mechanisms of action, its uses in various cancers ... Read more

The global bone marrow transplant market is estimated to be valued at US$ 10,356.1 million in 2023 and is expected to exhibit a CAGR of 4.0% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.

Market Overview:
Bone marrow transplant refers to a medical procedure that involves the replacement of diseased or damaged bone marrow with healthy bone marrow ... Read more

What is Leukemia?
Leukemia is a type of cancer that affects the blood and bone marrow. It causes the body to make abnormal white blood cells known as leukemia cells or blast cells. These abnormal cells do not function like normal white blood cells and are not able to fight infection effectively. Over time, they build up in the bone marrow and spill over into the bloodstream. There are four main types of leukemia - acute lymphoblastic leukemia, chronic lymphoblastic leukemia, acute ... Read more